Item 8.01. Other Events.

iBio, Inc., a Delaware corporation (the "Company"), closed an underwritten public offering of an aggregate of 29,661,017 shares (the "Shares") of common stock, par value $0.001 per share (the "Common Stock"), on December 10, 2020. As part of that offering, the underwriter was provided a thirty-day option to acquire up to 4,449,152 additional Shares (the "Option Shares") of the Company's Common Stock. The underwriter notified the Company of its decision to partially exercise the option, and on January 11, 2021, the Company issued an additional 4,240,828 Shares to satisfy the underwriter's option exercise. The Option Shares were purchased by the underwriter from the Company at a price of $1.0955 per share. The difference between the price at which the underwriter purchased the Option Shares from the Company and the higher price at which the underwriter may opt to resell such shares may be deemed underwriting compensation. The underwriter's purchase of the Option Shares generated additional gross proceeds for the Company of approximately $4.6 million, bringing the total gross proceeds in the public offering to approximately $37.1 million.

© Edgar Online, source Glimpses